AbbVie: Skyrizi Met Endpoints in Phase 3 Plaque Psoriasis Study

Date : 01/14/2020 @ 2:37PM
Source : Dow Jones News
Stock : AbbVie Inc (ABBV)
Quote : 78.56  3.17 (4.20%) @ 12:36AM
AbbVie share price Chart
After Hours
Last Trade
Last $ 78.55 ▼ -0.01 (-0.01%)

AbbVie: Skyrizi Met Endpoints in Phase 3 Plaque Psoriasis Study

Historical Stock Chart

3 Months : From Jan 2020 to Apr 2020

Click Here for more AbbVie Charts.

By Michael Dabaie


AbbVie Inc. (ABBV) said Skyrizi met the primary and all ranked secondary endpoints, including superiority at week 52, versus Cosentyx in a head-to-head Phase 3 study in adults with moderate to severe plaque psoriasis.

Skyrizi showed significantly higher rates of skin clearance compared with Cosentyx, meeting the primary endpoint of superiority with at least a 90% improvement from baseline in the Psoriasis Area and Severity Index at week 52, AbbVie said.

AbbVie shares were up 1% to $87.64 premarket trade Tuesday.

The safety profile of Skyrizi was consistent with that observed in previously reported studies, with no new safety signals observed through week 52, the company said.

Skyrizi is part of a collaboration between Boehringer Ingelheim and AbbVie, with AbbVie leading development and commercialization globally.


Write to Michael Dabaie at


(END) Dow Jones Newswires

January 14, 2020 09:22 ET (14:22 GMT)

Copyright (c) 2020 Dow Jones & Company, Inc.

Latest ABBV Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts
Your Recent History
Gulf Keyst..
FTSE 100
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V:us D:20200409 02:36:45